Skip to content

Price / book at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
1.4×-0.4×
Medtronic logo
MedtronicMDT
2.1×-0.1×
InfuSystem Holdings logo
InfuSystem HoldingsINFU
3.2×+1.1×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
1.1×-0.3×
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
1.4×+0.4×

Other financials

Income statement

See full
Revenue$19.9M+14.6%
Gross profit$6.1M+5.8%
Operating income$3.1M-15.0%
Net income$3.9M+20.2%
EPS (diluted)$1.20+22.4%

Balance sheet

See full
Cash & equivalents$10.0M+123%
Total debt$16.0M+43.2%
Total equity$45.2M+28.1%
Total assets$75.0M+16.7%

Cash flow

See full
Operating cash flow$1.6M+488%
CapEx$112.0K-37.8%
Free cash flow$1.5M

Valuation

See full
Market cap$195.81M+39.3%
Enterprise value$201.8M+34.4%
P/E16.3×+0.7×
P/S2.6×+0.5×

Profitability

See full
Gross margin27.8%-3.6pp
Operating margin14.5%-3.8pp
Net margin16.1%+1.5pp
FCF margin-3.8%+3.2pp

Returns & leverage

See full
Return on equity29.8%+1.5pp
Debt / equity0.4×0.0×
Current ratio3.7×+0.9×

Where this comes from

Calculated from Pro-Dex, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Pro-Dex, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pro-Dex, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pro-Dex, Inc.'s price / book?
Pro-Dex, Inc. (PDEX) reported price / book of 3.5× in Q1 2026.
How has Pro-Dex, Inc.'s price / book changed year-over-year?
Pro-Dex, Inc.'s price / book decreased by 24.0% year-over-year, from 4.6× to 3.5×.
What is the long-term trend for Pro-Dex, Inc.'s price / book?
Over 4 years (2021 to 2025), Pro-Dex, Inc.'s price / book has grown at a -8.1% compound annual growth rate (CAGR), from 5.3× to 3.8×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.